The Phase III trial compared the efficacy of Fasenra with the standard treatment of GSK’s Nucala in patients with ...

AstraZeneca’s FASENRA® (benralizumab) has been approved in the US for the treatment of adult patients with eosinophilic granulomatosis with polyangiitis (EGPA).1 EGPA is a rare, immune-mediated ...

EGPA, previously known as Churg-Strauss syndrome, is a rare inflammatory disorder characterized by asthma, necrotizing ...

That changed on Tuesday however, as the FDA signed off on Fasenra for patients with eosinophilic granulomatosis with ...

The parasite that causes the disease, Baylisascaris procyonis, lives in the intestines of raccoons. While it doesn't make ...

Endoscopic biopsies are essential in cell-mediated disorders and allergic eosinophilic gastropathies. Treatment includes avoidance of the offending food by a restriction diet in children and the ...

First described nearly 20 years ago, eosinophilic esophagitis (EoE ... both a rising incidence and increased recognition of this disorder. Treatment options available for patients with EoE ...

Post-Covid, there has been considerable advancement in integrating video conferencing into meeting spaces. However, users continue to seek more engaging and collaborative experiences, taking into ...

Seasonal allergies can cause more than just a stuffy nose. In some people, the condition can exacerbate mood disorders or related symptoms. Multiple studies have suggested an overlap between ...

Vivtex to apply its GI-ORIS™ technology to optimize oral bioavailability of EQ302, Equillium’s novel IL-15/IL-21 bi-specific peptide ...

Expert Systems, a leader in combining human and artificial intelligence to accelerate drug discovery, is expanding its operations in Europe through a strategic collaboration with Polku Therapeutics Oy ...

“Also, myasthenia gravis – this autoimmune disorder affects the neuromuscular junction ... it could be a condition called eosinophilic oesophagitis (EoE). Chest pain and regurgitation can also occur.